Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)
Clinical Aspects of Thymulin (FTS)
Thymulin, formerly called FTS (facteur thymique sérique), is a peptide initially prepared from porcine serum but also isolated to purity from human serum and calf thymus.
KeywordsExperimental Allergic Encephalomyelitis Mycosis Fungoides Ataxia Telangiectasia Thymic Epithelial Cell Common Variable Immunodeficiency
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Bach, J.-F., 1983, Spivn In: Clinics in Immunology and Allergy ,Vol. 3, p. 133, Saunders, Philadelphia.Google Scholar
- Bach, J.-F., Bach, M. A., Blanot, D., Bricas, E., Bricas, D., Charreire, J., Dardenne, M., Fournier, C., and Pléau, J. M., 1978, Thymic serum factor (FTS), Bull. Inst. Pasteur (Paris) 76:325.Google Scholar
- Bach, M. A., 1974, Transient loss of theta antigen after indomethacin treatment, Ann. Immunol. 125c:325.Google Scholar
- Dardenne, M., 1983, Evaluation of thymic hormone serum levels in health and disease, in: Clinics in Immunology and Allergy, Vol. 3, p. 157, Saunders, Philadelphia.Google Scholar
- Faure, G., Bordigoni, P., Bene, M. C., Olive, D., and Duheille, J., 1983, Thymic factor therapy of primary T lymphocyte immunodeficiencies, in: Serono Symposium, Academic Press, New York.Google Scholar
© Plenum Press, New York 1984